Stanley Chetcuti, MD
Cardiovascular Disease · Ann Arbor, MINPI 1467503516
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (46.1%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Medtronic accounts for 94.3% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $155,691, 3.4 times the $46,050 reported in 2019. Among cardiovascular disease clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,462 payments — averaging $391.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$540K
- Abbott$13K
- Boston Scientific$8K
- Edwards Lifesciences$7K
- Philips North America LLC$2K
- Siemens Medical Solutions USA, Inc.$1K
- plus $2K from 8 others
Across 766 payments — averaging $4978.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$1.9M
- Edwards Lifesciences$874K
- Boston Scientific$506K
- W. L. Gore & Associates, Inc.$181K
- Jenavalve Technology, Inc.$152K
- Abbott$123K
- plus $118K from 2 others
What the payments were for
- Consulting fees$88,31915%
- Speaking & faculty fees$264,17546%
- Travel & lodging$166,83029%
- Food & beverage$53,3859%
- Education$60%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 1,273 | $539,926 |
| Abbott | 61 | $12,830 |
| Boston Scientific | 29 | $8,218 |
| Edwards Lifesciences | 61 | $7,254 |
| Philips North America LLC | 12 | $1,594 |
| Siemens Medical Solutions USA, Inc. | 11 | $1,327 |
| Jenavalve Technology, Inc. | 3 | $626 |
| Shockwave Medical, Inc | 3 | $279 |
| Almirall LLC | 2 | $150 |
| Abiomed | 1 | $143 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $138 |
| Cardiovascular Systems Inc. | 1 | $99 |
| Teleflex LLC | 1 | $94 |
| Amgen | 1 | $37 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$204,873
- CoreValve Evolut$146,991
- APOLLOTM$42,773
- Resolute$17,498
- NAVITOR$8,126
- GENERAL - STRUCTURAL HEART$5,128
- GENERAL - THERAPIES$2,087
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,687
- CorPath Imaging System$817
- SAPIEN 3 Ultra RESILIA$788
- PORTICO$680
- JenaValve Pericardial TAVR System$626
- MitraClip$602
- (BQ9) Coronary IVUS$539
- SYMPLICITY G3$527
- (9520) IGT Devices Undivided$379
- Tricuspid Valve Repair System$281
- (9525) Intracardiac Und$241
- MitraClip System$163
- Avalus$156
How this compares
$572,715 in reported general payments places this provider in the 95th percentile of 760 cardiovascular disease providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 28 | $36,429 |
| Ranolazine ErRanolazine | 15 | $2,161 |
| ClopidogrelClopidogrel Bisulfate | 99 | $1,752 |
| Metoprolol Succinate | 72 | $1,422 |
| Atorvastatin Calcium | 66 | $1,298 |
| Rosuvastatin Calcium | 53 | $1,237 |
| Ezetimibe | 20 | $737 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 21 | $437 |
| Lisinopril | 45 | $386 |
| Amlodipine Besylate | 44 | $339 |
| Carvedilol | 18 | $199 |
| Metoprolol Tartrate | 22 | $177 |
| Nifedipine ErNifedipine | 11 | $171 |
| Furosemide | 16 | $130 |
| Hydrochlorothiazide | 19 | $126 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Ann Arbor
- Marschall RungeAnn Arbor$1.8M
- Vallerie McLaughlinAnn Arbor$947K
- David BachAnn Arbor$390K
- Bertram PittAnn Arbor$298K
- Victor MolesAnn Arbor$120K
- Salim HayekAnn Arbor$92K
- Ashwini KerkarAnn Arbor$84K
- Priya MehtaAnn Arbor$70K
- Raymond YeowAnn Arbor$61K
- Eric GoodAnn Arbor$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.